What is Manhattan Associates Inc's earnings per share (EPS)?

Manhattan Associates Inc (MANH) reported diluted earnings per share of $3.60 for fiscal year 2025. This represents a 2.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Manhattan Associates Inc Financials

MANH

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Manhattan Associates Inc (MANH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 68/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Manhattan Associates Inc has an operating margin of 25.9%, meaning the company retains $26 of operating profit per $100 of revenue. This strong profitability earns a score of 80/100, reflecting efficient cost management and pricing power. This is up from 25.1% the prior year.

Growth

Manhattan Associates Inc's revenue grew a modest 3.7% year-over-year to $1.1B. This slow but positive growth earns a score of 40/100.

Leverage

Manhattan Associates Inc carries a low D/E ratio of 1.67, meaning only $1.67 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 68/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Manhattan Associates Inc's current ratio of 1.28 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 21/100, which could limit financial flexibility.

Cash Flow

100

Manhattan Associates Inc converts 34.6% of revenue into free cash flow ($374.0M). This strong cash generation earns a score of 100/100.

Returns

100

Manhattan Associates Inc earns a strong 69.9% return on equity (ROE), meaning it generates $70 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100. This is down from 73.0% the prior year.

Altman Z-Score Safe

12.26

Manhattan Associates Inc scores 12.26, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($8.0B) relative to total liabilities ($524.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

6/9

Manhattan Associates Inc passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.77x

For every $1 of reported earnings, Manhattan Associates Inc generates $1.77 in operating cash flow ($389.5M OCF vs $219.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

63.8x

Manhattan Associates Inc earns $63.8 in operating income for every $1 of interest expense ($279.8M vs $4.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.1B

YoY+3.7%

5Y CAGR+13.0%

10Y CAGR+23.5%

Manhattan Associates Inc generated $1.1B in revenue in fiscal year 2025. This represents an increase of 3.7% from the prior year.

EBITDA

$286.1M

YoY+6.8%

5Y CAGR+18.4%

10Y CAGR+5.4%

Manhattan Associates Inc's EBITDA was $286.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.8% from the prior year.

Net Income

$219.9M

YoY+0.7%

5Y CAGR+20.3%

10Y CAGR+7.8%

Manhattan Associates Inc reported $219.9M in net income in fiscal year 2025. This represents an increase of 0.7% from the prior year.

EPS (Diluted)

$3.60

YoY+2.6%

5Y CAGR+21.5%

10Y CAGR+9.9%

Manhattan Associates Inc earned $3.60 per diluted share (EPS) in fiscal year 2025. This represents an increase of 2.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$374.0M

YoY+30.6%

5Y CAGR+22.0%

10Y CAGR+13.2%

Manhattan Associates Inc generated $374.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 30.6% from the prior year.

Cash & Debt

$328.7M

YoY+23.5%

5Y CAGR+9.9%

10Y CAGR+10.8%

Manhattan Associates Inc held $328.7M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

60M

YoY-2.1%

5Y CAGR-1.3%

10Y CAGR-2.0%

Manhattan Associates Inc had 60M shares outstanding in fiscal year 2025. This represents a decrease of 2.1% from the prior year.

Margins & Returns

Gross Margin

56.3%

YoY+1.5pp

5Y CAGR+2.4pp

10Y CAGR+135.6pp

Manhattan Associates Inc's gross margin was 56.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.5 percentage points from the prior year.

Operating Margin

25.9%

YoY+0.8pp

5Y CAGR+6.4pp

10Y CAGR-97.1pp

Manhattan Associates Inc's operating margin was 25.9% in fiscal year 2025, reflecting core business profitability. This is up 0.8 percentage points from the prior year.

Net Margin

20.3%

YoY-0.6pp

5Y CAGR+5.5pp

10Y CAGR-58.5pp

Manhattan Associates Inc's net profit margin was 20.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.6 percentage points from the prior year.

Return on Equity

69.9%

YoY-3.1pp

5Y CAGR+30.0pp

10Y CAGR+16.9pp

Manhattan Associates Inc's ROE was 69.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.1 percentage points from the prior year.

Capital Allocation

R&D Spending

$145.1M

YoY+5.4%

5Y CAGR+11.5%

10Y CAGR+10.4%

Manhattan Associates Inc invested $145.1M in research and development in fiscal year 2025. This represents an increase of 5.4% from the prior year.

Share Buybacks

$315.2M

YoY+10.1%

5Y CAGR+48.6%

10Y CAGR+10.9%

Manhattan Associates Inc spent $315.2M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 10.1% from the prior year.

Capital Expenditures

$15.5M

YoY+78.2%

5Y CAGR+41.4%

10Y CAGR+3.0%

Manhattan Associates Inc invested $15.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 78.2% from the prior year.

MANH Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.1B+3.7%	$1.0B+12.2%	$928.7M+21.1%	$767.1M+15.6%	$663.6M+13.2%	$586.4M
Cost of Revenue	$472.3M+0.3%	$471.0M+9.4%	$430.6M+20.2%	$358.2M+20.3%	$297.8M+10.4%	$269.9M
Gross Profit	$609.1M+6.6%	$571.4M+14.7%	$498.1M+21.8%	$408.8M+11.8%	$365.8M+15.6%	$316.5M
R&D Expenses	$145.1M+5.4%	$137.7M+8.6%	$126.8M+13.4%	$111.9M+14.6%	$97.6M+15.8%	$84.3M
SG&A Expenses	$93.8M+4.4%	$89.8M+10.6%	$81.2M+11.1%	$73.1M+7.3%	$68.1M+10.8%	$61.4M
Operating Income	$279.8M+7.0%	$261.6M+24.6%	$209.9M+37.4%	$152.7M+13.7%	$134.3M+17.8%	$114.1M
Interest Expense	$4.4M-27.2%	$6.0M+13.7%	$5.3M+789.9%	$596K+776.5%	$68K-30.6%	$98K
Income Tax	$65.9M+36.1%	$48.5M+30.6%	$37.1M+27.2%	$29.2M+23.6%	$23.6M-11.1%	$26.5M
Net Income	$219.9M+0.7%	$218.4M+23.7%	$176.6M+36.9%	$129.0M+16.7%	$110.5M+26.6%	$87.2M
EPS (Diluted)	$3.60+2.6%	$3.51+24.5%	$2.82+38.9%	$2.03+18.0%	$1.72+26.5%	$1.36

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$270.4M-2.0%	$275.8M+1.2%	$272.4M+3.7%	$262.8M+2.7%	$255.8M-4.1%	$266.7M+0.5%	$265.3M+4.2%	$254.6M
Cost of Revenue	$121.7M+1.6%	$119.8M+3.1%	$116.2M+1.4%	$114.6M+1.4%	$113.0M-4.8%	$118.7M-1.2%	$120.0M+0.6%	$119.3M
Gross Profit	$148.6M-4.7%	$156.0M-0.1%	$156.2M+5.4%	$148.2M+3.8%	$142.8M-3.5%	$148.0M+1.9%	$145.3M+7.4%	$135.3M
R&D Expenses	$38.5M+6.0%	$36.4M+4.3%	$34.9M-1.2%	$35.3M+7.0%	$33.0M-3.9%	$34.3M-2.8%	$35.3M+0.9%	$35.0M
SG&A Expenses	$19.5M-19.1%	$24.1M-7.3%	$26.0M+7.3%	$24.2M-10.9%	$27.2M+33.9%	$20.3M-3.8%	$21.1M-0.4%	$21.2M
Operating Income	$67.0M-11.6%	$75.8M+2.8%	$73.8M+16.8%	$63.2M+4.1%	$60.7M-19.2%	$75.1M+10.1%	$68.2M+18.3%	$57.6M
Interest Expense	$1.4M+41.9%	$1.0M+18.2%	$852K-22.6%	$1.1M-25.4%	$1.5M-9.8%	$1.6M+8.8%	$1.5M+6.3%	$1.4M
Income Tax	$16.5M-16.7%	$19.8M+11.7%	$17.7M+48.6%	$11.9M-18.7%	$14.7M+16.2%	$12.6M-22.7%	$16.3M+238.6%	$4.8M
Net Income	$52.0M-11.4%	$58.6M+3.3%	$56.8M+8.0%	$52.6M+9.5%	$48.0M-24.7%	$63.8M+20.9%	$52.8M-1.9%	$53.8M
EPS (Diluted)	N/A	$0.96+3.2%	$0.93+9.4%	$0.85	N/A	$1.03+21.2%	$0.85-1.2%	$0.86

MANH Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$839.4M+10.8%	$757.6M+12.5%	$673.4M+18.1%	$570.2M+5.6%	$539.7M+16.0%	$465.4M
Current Assets	$583.3M+15.9%	$503.3M+5.0%	$479.2M+15.4%	$415.4M+1.7%	$408.4M+22.3%	$334.0M
Cash & Equivalents	$328.7M+23.5%	$266.2M-1.7%	$270.7M+20.1%	$225.5M-14.5%	$263.7M+28.8%	$204.7M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$214.7M+4.5%	$205.5M+13.4%	$181.2M+8.6%	$166.8M+34.0%	$124.4M+13.9%	$109.2M
Goodwill	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.3M
Total Liabilities	$524.6M+14.4%	$458.4M+16.0%	$395.1M+15.1%	$343.4M+18.8%	$289.1M+17.3%	$246.5M
Current Liabilities	$455.9M+13.9%	$400.3M+9.4%	$365.9M+15.9%	$315.6M+26.7%	$249.0M+26.4%	$197.0M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$314.8M+5.2%	$299.1M+7.5%	$278.3M+22.7%	$226.8M-9.5%	$250.6M+14.5%	$218.9M
Retained Earnings	$345.1M+4.8%	$329.4M+8.1%	$304.7M+20.1%	$253.7M-6.0%	$269.8M+14.1%	$236.5M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$839.4M+9.2%	$768.8M+3.2%	$744.7M+5.1%	$708.2M-6.5%	$757.6M+8.5%	$698.1M+4.9%	$665.3M-1.4%	$674.8M
Current Assets	$583.3M+10.9%	$525.8M+8.8%	$483.3M+6.2%	$455.3M-9.5%	$503.3M+11.3%	$452.3M+6.1%	$426.1M-4.3%	$445.2M
Cash & Equivalents	$328.7M+24.7%	$263.6M+14.3%	$230.6M+12.0%	$205.9M-22.7%	$266.2M+23.9%	$215.0M+6.0%	$202.7M-2.3%	$207.5M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$214.7M-2.2%	$219.6M+4.6%	$209.8M-0.4%	$210.7M+2.5%	$205.5M+2.9%	$199.8M+4.5%	$191.2M-7.0%	$205.7M
Goodwill	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M
Total Liabilities	$524.6M+14.1%	$459.6M-1.4%	$465.9M+0.6%	$463.1M+1.0%	$458.4M+9.1%	$420.2M-1.1%	$424.7M-2.4%	$435.2M
Current Liabilities	$455.9M+13.9%	$400.4M-1.7%	$407.2M+0.5%	$405.0M+1.2%	$400.3M+10.5%	$362.2M-0.1%	$362.7M-2.5%	$372.0M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$314.8M+1.8%	$309.2M+10.9%	$278.8M+13.7%	$245.1M-18.1%	$299.1M+7.6%	$278.0M+15.5%	$240.6M+0.4%	$239.6M
Retained Earnings	$345.1M+1.9%	$338.7M+11.2%	$304.5M+11.1%	$274.1M-16.8%	$329.4M+8.6%	$303.4M+13.3%	$267.8M+0.4%	$266.8M

MANH Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$389.5M+32.0%	$295.0M+19.8%	$246.2M+37.1%	$179.6M-3.0%	$185.2M+31.4%	$140.9M
Capital Expenditures	$15.5M+78.2%	$8.7M+83.4%	$4.7M-28.2%	$6.6M+64.0%	$4.0M+47.1%	$2.7M
Free Cash Flow	$374.0M+30.6%	$286.3M+18.6%	$241.5M+39.6%	$173.0M-4.5%	$181.2M+31.1%	$138.2M
Investing Cash Flow	-$15.5M-78.2%	-$8.7M-83.4%	-$4.7M+28.2%	-$6.6M-64.0%	-$4.0M-47.1%	-$2.7M
Financing Cash Flow	-$315.2M-10.1%	-$286.4M-46.1%	-$196.0M+4.1%	-$204.5M-69.8%	-$120.4M-176.4%	-$43.6M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$315.2M+10.1%	$286.4M+46.1%	$196.0M-4.1%	$204.5M+69.8%	$120.4M+176.4%	$43.6M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$147.1M+57.9%	$93.1M+25.7%	$74.0M-1.6%	$75.3M-28.1%	$104.7M+68.1%	$62.3M-15.0%	$73.3M+33.8%	$54.7M
Capital Expenditures	$4.7M-21.4%	$5.9M+48.9%	$4.0M+346.7%	$891K-71.5%	$3.1M+210.0%	$1.0M-54.5%	$2.2M-4.5%	$2.3M
Free Cash Flow	$142.4M+63.3%	$87.2M+24.4%	$70.1M-5.8%	$74.4M-26.8%	$101.6M+65.7%	$61.3M-13.7%	$71.0M+35.5%	$52.4M
Investing Cash Flow	-$4.7M+21.4%	-$5.9M-48.9%	-$4.0M-346.7%	-$891K+71.5%	-$3.1M-210.0%	-$1.0M+54.5%	-$2.2M+4.5%	-$2.3M
Financing Cash Flow	-$77.0M-49.3%	-$51.5M-2.7%	-$50.2M+63.2%	-$136.4M-201.8%	-$45.2M+12.4%	-$51.6M+31.8%	-$75.7M+33.5%	-$113.8M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$77.0M+49.3%	$51.5M+2.7%	$50.2M-63.2%	$136.4M+201.8%	$45.2M-12.4%	$51.6M-31.8%	$75.7M-33.5%	$113.8M

MANH Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	56.3%+1.5pp	54.8%+1.2pp	53.6%+0.3pp	53.3%-1.8pp	55.1%+1.2pp	54.0%
Operating Margin	25.9%+0.8pp	25.1%+2.5pp	22.6%+2.7pp	19.9%-0.3pp	20.2%+0.8pp	19.4%
Net Margin	20.3%-0.6pp	20.9%+1.9pp	19.0%+2.2pp	16.8%+0.2pp	16.7%+1.8pp	14.9%
Return on Equity	69.9%-3.1pp	73.0%+9.6pp	63.4%+6.6pp	56.9%+12.8pp	44.1%+4.2pp	39.9%
Return on Assets	26.2%-2.6pp	28.8%+2.6pp	26.2%+3.6pp	22.6%+2.2pp	20.5%+1.7pp	18.7%
Current Ratio	1.28+0.0	1.26-0.1	1.310.0	1.32-0.3	1.64-0.1	1.70
Debt-to-Equity	1.67+0.1	1.53+0.1	1.42-0.1	1.51+0.4	1.15+0.0	1.13
FCF Margin	34.6%+7.1pp	27.5%+1.5pp	26.0%+3.4pp	22.6%-4.7pp	27.3%+3.7pp	23.6%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	55.0%-1.6pp	56.6%-0.8pp	57.3%+0.9pp	56.4%+0.6pp	55.8%+0.3pp	55.5%+0.7pp	54.8%+1.6pp	53.1%
Operating Margin	24.8%-2.7pp	27.5%+0.4pp	27.1%+3.0pp	24.0%+0.3pp	23.7%-4.4pp	28.2%+2.5pp	25.7%+3.1pp	22.6%
Net Margin	19.2%-2.1pp	21.3%+0.4pp	20.8%+0.8pp	20.0%+1.2pp	18.8%-5.1pp	23.9%+4.0pp	19.9%-1.3pp	21.1%
Return on Equity	16.5%-2.4pp	19.0%-1.4pp	20.4%-1.1pp	21.4%+5.4pp	16.1%-6.9pp	22.9%+1.0pp	21.9%-0.5pp	22.4%
Return on Assets	6.2%-1.4pp	7.6%+0.0pp	7.6%+0.2pp	7.4%+1.1pp	6.3%-2.8pp	9.1%+1.2pp	7.9%-0.0pp	8.0%
Current Ratio	1.28-0.0	1.31+0.1	1.19+0.1	1.12-0.1	1.260.0	1.25+0.1	1.17-0.0	1.20
Debt-to-Equity	1.67+0.2	1.49-0.2	1.67-0.2	1.89+0.4	1.53+0.0	1.51-0.3	1.76-0.1	1.82
FCF Margin	52.7%+21.0pp	31.6%+5.9pp	25.7%-2.6pp	28.3%-11.4pp	39.7%+16.7pp	23.0%-3.8pp	26.8%+6.2pp	20.6%

Similar Companies

Paycom Software Inc PAYC

$6.5B

Full Truck Alliance Co Ltd YMM

$8.7B

Dynatrace Inc DT

$11.0B

Appfolio APPF

$5.7B

Bentley Systems Inc BSY

$10.6B

Frequently Asked Questions

What is Manhattan Associates Inc's annual revenue?

Manhattan Associates Inc (MANH) reported $1.1B in total revenue for fiscal year 2025. This represents a 3.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Manhattan Associates Inc's revenue growing?

Manhattan Associates Inc (MANH) revenue grew by 3.7% year-over-year, from $1.0B to $1.1B in fiscal year 2025.

Is Manhattan Associates Inc profitable?

Yes, Manhattan Associates Inc (MANH) reported a net income of $219.9M in fiscal year 2025, with a net profit margin of 20.3%.

What is Manhattan Associates Inc's EBITDA?

Manhattan Associates Inc (MANH) had EBITDA of $286.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Manhattan Associates Inc's gross margin?

Manhattan Associates Inc (MANH) had a gross margin of 56.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Manhattan Associates Inc's operating margin?

Manhattan Associates Inc (MANH) had an operating margin of 25.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Manhattan Associates Inc's net profit margin?

Manhattan Associates Inc (MANH) had a net profit margin of 20.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Manhattan Associates Inc's return on equity (ROE)?

Manhattan Associates Inc (MANH) has a return on equity of 69.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Manhattan Associates Inc's free cash flow?

Manhattan Associates Inc (MANH) generated $374.0M in free cash flow during fiscal year 2025. This represents a 30.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Manhattan Associates Inc's operating cash flow?

Manhattan Associates Inc (MANH) generated $389.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Manhattan Associates Inc's total assets?

Manhattan Associates Inc (MANH) had $839.4M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Manhattan Associates Inc's capital expenditures?

Manhattan Associates Inc (MANH) invested $15.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Manhattan Associates Inc spend on research and development?

Manhattan Associates Inc (MANH) invested $145.1M in research and development during fiscal year 2025.

Does Manhattan Associates Inc buy back shares?

Yes, Manhattan Associates Inc (MANH) spent $315.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Manhattan Associates Inc have outstanding?

Manhattan Associates Inc (MANH) had 60M shares outstanding as of fiscal year 2025.

What is Manhattan Associates Inc's current ratio?

Manhattan Associates Inc (MANH) had a current ratio of 1.28 as of fiscal year 2025, which is considered adequate.

What is Manhattan Associates Inc's debt-to-equity ratio?

Manhattan Associates Inc (MANH) had a debt-to-equity ratio of 1.67 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Manhattan Associates Inc's return on assets (ROA)?

Manhattan Associates Inc (MANH) had a return on assets of 26.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Manhattan Associates Inc's Altman Z-Score?

Manhattan Associates Inc (MANH) has an Altman Z-Score of 12.26, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Manhattan Associates Inc's Piotroski F-Score?

Manhattan Associates Inc (MANH) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Manhattan Associates Inc's earnings high quality?

Manhattan Associates Inc (MANH) has an earnings quality ratio of 1.77x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Manhattan Associates Inc cover its interest payments?

Manhattan Associates Inc (MANH) has an interest coverage ratio of 63.8x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Manhattan Associates Inc?

Manhattan Associates Inc (MANH) scores 68 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.